Servicio de Anestesiologia-Instituto Oncologico Angel Roffo-UBA- Buenos Aires-Argentina

Mayoral-Silva A, Ascencio-Ibarra HC Consideraciones anestésicas para citorreducción y perfusión intraoperatoria intraperitoneal de quimioterapia hipertérmica Rev Mex Anest 2013; 36 (1) Idioma: Español Referencias bibliográficas: 57 Paginas: 37-46 Archivo PDF: 772.85 Kb. [Texto completo - PDF]  libre en internet

Indian J Surg Oncol.   2016  Jun;7(2):236-43. doi: 10.1007/s13193-016-0508-2. Epub   2016  Feb 20. Anaesthetic Considerations in the Perioperative Management of Cytoreductive Surgery and  Hyperthermic  Intraperitoneal Chemotherapy. Sheshadri  DB 1 ,  Chakravarthy MR 2 . Author information Abstract Cytoreductive surgery with  hyperthermic  intraperitoneal chemotherapy has emerged as one of the primary modalities of treatment of diffuse peritoneal malignancies. It is a complex surgical procedure with the patients facing major and potentially life threatening alterations of haemodynamic, respiratory, metabolic and thermal balance with significant fluid losses and the perioperative management is challenging for anaesthesiologists and intensive care physicians. Though the alterations are short lived, these patients require advanced organ function monitoring and support perioperatively. The anaesthesiologist is involved in the management of haemodynamics, respiratory functio

World J Surg Oncol.   2014  May 1;12:136. doi: 10.1186/1477-7819-12-136. Anaesthesia in patients undergoing  cytoreductive  surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. Kajdi  ME ,  Beck-Schimmer B ,  Held U ,  Kofmehl R ,  Lehmann K ,  Ganter MT 1 . Author information Abstract BACKGROUND: Cytoreductive  surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is a treatment option for selected patients with peritoneal carcinomatosis. There are limited data available on anaesthesia management and its impact on patients' outcome. Our aim was to retrospectively analyze and evaluate perioperative management and the clinical course of patients undergoing CRS/HIPEC within a three-year period. METHODS:  After ethic committee approval, patient charts were retrospectively reviewed for patient characteristics, interventions, perioperative management, postoperative course, a